secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nexentis Technologies Inc. (NXTS)
CIK:        0001789192
Form:       8-K
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001493152-26-007988
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 5.03, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

N2OFF rebrands to Nexentis Technologies, shifts focus to AI-driven mitochondrial biotech
--------------------------------------------------------------------------------

- Name change to Nexentis Technologies Inc. and ticker change to NXTS effective Feb 26, 2026.
- Rebranding reflects integration of MitoCareX Bio with MITOLINE platform targeting mitochondrial SLC25 carriers.
- Recent in vitro data showed anti-tumor activity and reduction in pro-inflammatory markers.
- Company continues to manage RTB solar energy investments as non-core asset base.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1789192/000149315226007988/0001493152-26-007988-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1789192/000149315226007988/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-007988

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer